Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Participants
Condition: Healthy
Interventions: Drug: Formulation A (ALS-008176); Drug: Formulation B (ALS-008176); Drug: Formulation C (ALS-008176); Drug: Formulation D (ALS-008176); Drug: Formulation E (ALS-008176); Drug: Formulation F (ALS-008176); Drug: Formulation G1 (ALS-008176); Drug: Formulation G2 (ALS-008176); Drug: Formulation G3 (ALS-008176); Drug: Formulation H1 (ALS-008176); Drug: Formulation H2 (ALS-008176); Drug: Formulation H3 (ALS-008176)
Sponsor: Janssen Research & Development, LLC
Interventions: Drug: Formulation A (ALS-008176); Drug: Formulation B (ALS-008176); Drug: Formulation C (ALS-008176); Drug: Formulation D (ALS-008176); Drug: Formulation E (ALS-008176); Drug: Formulation F (ALS-008176); Drug: Formulation G1 (ALS-008176); Drug: Formulation G2 (ALS-008176); Drug: Formulation G3 (ALS-008176); Drug: Formulation H1 (ALS-008176); Drug: Formulation H2 (ALS-008176); Drug: Formulation H3 (ALS-008176)
Sponsor: Janssen Research & Development, LLC